Kim JS, Lee G, Park KI, Oh SW
In STEP-1 (Wilding et al., NEJM 2021), 68 weeks of once-weekly 2.4 mg semaglutide plus lifestyle intervention produced a mean body-weight reduction of about 15%, versus about 2.4% with placebo a large, clinically meaningful, well-replicated effect
How Long the Study Lasts 1 year of participation for each person Dose ramp-up: first 6 months Maintenance: next 6 months But theres a key checkpoint: At 3 months: An independent safety board examines unblinded data
Credit to the PCAC members, clinicians, researchers, patient advocates and industry leaders who brought the science, evidence and patient perspective into this process
MD Touch Aesthetics and Wellness in Coral Springs, led by Dr
Knowledge is freedom